These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3226031)

  • 1. [Adverse reactions of antituberculous drugs].
    Hagiwara T; Morita Y; Yamaguchi H; Ishikawa H; Ueda S; Horie T; Okayasu M
    Kekkaku; 1988 Dec; 63(12):763-71. PubMed ID: 3226031
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse reactions of antituberculous agents].
    Kobashi Y; Niki Y; Kawane H; Matsushima T
    Kekkaku; 1998 Jul; 73(7):485-90. PubMed ID: 9739581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence and nature of adverse reactions to antitubercular drugs in children with primary intrathoracic tuberculosis].
    Kurmanova NK
    Probl Tuberk; 1988; (6):33-6. PubMed ID: 2974988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary tuberculosis with chemotherapy related liver dysfunction].
    Yasuda K; Sato A; Chida K; Shichi I; Kishimoto H; Wada R; Tatsuta Y; Honda A; Yamazaki A
    Kekkaku; 1990 Jun; 65(6):407-13. PubMed ID: 2388450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs].
    Mishin VIu; Vasil'eva IA; Makieva VG; Kuz'mina NV; Prikazchikova AV; Khoroshutina VV
    Probl Tuberk Bolezn Legk; 2003; (7):24-9. PubMed ID: 12939872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver damage of allergic origin during treatment with antitubercular agents].
    Kürti V; Novák O
    Cas Lek Cesk; 1968 Jun; 107(26):780-4. PubMed ID: 5661073
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Antituberculous Drugs on Serum Uric Acid and Urine Uric Acid Excretion.
    Louthrenoo W; Hongsongkiat S; Kasitanon N; Wangkaew S; Jatuworapruk K
    J Clin Rheumatol; 2015 Oct; 21(7):346-8. PubMed ID: 26398460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
    Shmelev EI; Stepanian IE
    Probl Tuberk; 1996; (6):57-60. PubMed ID: 9019774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver and antitubercular drug therapy].
    Viroglio AL; Piñeyro JO; Acosta A; Munaro N; Escarguel Malbrán J; Pérez JA
    Rev Fac Cienc Med Cordoba; 1974; 32(1):19-36. PubMed ID: 4458009
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse drug reactions in TB therapy: risks and recommendations.
    Yoshikawa TT; Nagami PH
    Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatotoxicity of antituberculous drugs.
    Rao NK; Wadia RS; Karve SR; Grant KB
    J Assoc Physicians India; 1982 May; 30(5):295-8. PubMed ID: 7169440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison between two strategies for monitoring hepatic function during antituberculous therapy.
    Singanayagam A; Sridhar S; Dhariwal J; Abdel-Aziz D; Munro K; Connell DW; George PM; Molyneaux PL; Cooke GS; Burroughs AK; Lalvani A; Wickremasinghe M; Kon OM
    Am J Respir Crit Care Med; 2012 Mar; 185(6):653-9. PubMed ID: 22198973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin in treatment of advanced pulmonary tuberculosis. Report of a VA cooperative pilot study.
    Raleigh JW
    Am Rev Respir Dis; 1972 Mar; 105(3):397-409. PubMed ID: 5011668
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity and antituberculosis therapy: time to revise UK guidance?
    Walker NF; Kliner M; Turner D; Bhagani S; Cropley I; Hopkins S; Lipman M
    Thorax; 2009 Oct; 64(10):918. PubMed ID: 19786720
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)].
    Estay S; Armas Merino R; Busel I; Baier E; Wolff C; Jabsa Z
    Rev Med Chil; 1981 Mar; 109(3):212-20. PubMed ID: 7280406
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1988 Apr; 30(763):43-4. PubMed ID: 3352531
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the prevention of side-effects by antituberculous drugs with special reference to effectiveness of pantethine (author's transl)].
    Aoyagi T; Yamada Y; Kaneko K; Aizawa Y; Nanba A; Watabiki S; Kakazu Y; Hasegawa T; Fukuhara Y; Matumiya T; Komoriya T; Yoshida F; Kawamoto H; Ozawa R; Nishiyama K; Takahashi S; Nukada H; Kawame S; Fujita S; Oosato T; Murata A; Ishihara M; Kita R; Yoshitake H; Honda A; Hashimoto S; Kida E
    Kekkaku; 1977 Nov; 52(11):563-8. PubMed ID: 599776
    [No Abstract]   [Full Text] [Related]  

  • 20. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.